|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-3-21
|
|
pubmed:abstractText |
[corrected] Entacapone was given to try to improve the motor complications in eight patients with Parkinson's disease (PD) treated chronically with levodopa, with daily severe motor fluctuations and dyskinesias.
|
|
pubmed:language |
spa
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0213-4853
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
81-4
|
|
pubmed:dateRevised |
2008-7-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11257935-Aged,
pubmed-meshheading:11257935-Antiparkinson Agents,
pubmed-meshheading:11257935-Apomorphine,
pubmed-meshheading:11257935-Catechol O-Methyltransferase,
pubmed-meshheading:11257935-Catechols,
pubmed-meshheading:11257935-Dopamine,
pubmed-meshheading:11257935-Drug Therapy, Combination,
pubmed-meshheading:11257935-Dyskinesias,
pubmed-meshheading:11257935-Humans,
pubmed-meshheading:11257935-Levodopa,
pubmed-meshheading:11257935-Nitriles,
pubmed-meshheading:11257935-Parkinson Disease
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
[Motor impairment, in patients with severe Parkinson's disease, associated with dopaminergic hyperstimulation (entacapone)].
|
|
pubmed:affiliation |
Servicio de Neurología, Complejo Hospitalario de Ciudad Real.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
